Medexus Pharmaceuticals (MEDXF) Earnings Date & Reports
Medexus Pharmaceuticals Inc is a specialty pharmaceutical company with a powerful North American commercial platform and a growing portfolio of inventive and rare disease treatment solutions... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MEDXF is expected to report earnings to rise 162.00% to -5 cents per share on August 06
Q2'25
Est.
$-0.05
Q1'25
Beat
by $0.05
The last earnings report on June 25 showed earnings per share of -1 cents, beating the estimate of -6 cents. With 6.76K shares outstanding, the current market capitalization sits at 31.92M.